Mark Socinski, MD, Gilberto Lopes, MD, Afsaneh Barzi, MD, PhD, and Jack West, MD, discuss the balance of using innovative cancer therapies with disruptive drug prices to make the therapies more widely available.
EP. 2: Role of Financial Toxicity on Treatment Decisions
Experts in various specialties of oncology management share their insights on the role of financial toxicity on making treatment decisions for patients.
EP. 3: Personalized Therapies Based on Innovation and Affordability
Gilberto Lopes, MD, and Afsaneh Barzi, MD, PhD, discuss personalized treatment plans based on innovative therapies and affordability.
EP. 5: EGFR-Targeted TKIs in NSCLC and Cost
Mark Socinski, MD, Gilberto Lopes, MD, and Jack West, MD, provide an overview of the role of EGFR-targeted TKIs in NSCLC and the costs.